These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 14631378

  • 1. Upregulation of tissue inhibitor of metalloproteinases (TIMP)-2 promotes matrix metalloproteinase (MMP)-2 activation and cell invasion in a human glioblastoma cell line.
    Lu KV, Jong KA, Rajasekaran AK, Cloughesy TF, Mischel PS.
    Lab Invest; 2004 Jan; 84(1):8-20. PubMed ID: 14631378
    [Abstract] [Full Text] [Related]

  • 2. The essential roles of matrix metalloproteinase-2, membrane type 1 metalloproteinase and tissue inhibitor of metalloproteinase-2 in the invasive capacity of acute monocytic leukemia SHI-1 cells.
    Wang C, Chen Z, Li Z, Cen J.
    Leuk Res; 2010 Aug; 34(8):1083-90. PubMed ID: 20138666
    [Abstract] [Full Text] [Related]

  • 3. Analysis of tissue inhibitor of metalloproteinases-2 effect on pro-matrix metalloproteinase-2 activation by membrane-type 1 matrix metalloproteinase using baculovirus/insect-cell expression system.
    Jo Y, Yeon J, Kim HJ, Lee ST.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):511-9. PubMed ID: 10642509
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Park HJ, Lee HJ, Min HY, Chung HJ, Suh ME, Park-Choo HY, Kim C, Kim HJ, Seo EK, Lee SK.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):31-6. PubMed ID: 16309669
    [Abstract] [Full Text] [Related]

  • 6. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct 19; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
    Hofmann UB, Westphal JR, Waas ET, Zendman AJ, Cornelissen IM, Ruiter DJ, van Muijen GN.
    Br J Cancer; 1999 Nov 19; 81(5):774-82. PubMed ID: 10555745
    [Abstract] [Full Text] [Related]

  • 9. Mechanisms of the inhibitory effect of epigallocatechin-3-gallate on cultured human vascular smooth muscle cell invasion.
    Cheng XW, Kuzuya M, Nakamura K, Liu Z, Di Q, Hasegawa J, Iwata M, Murohara T, Yokota M, Iguchi A.
    Arterioscler Thromb Vasc Biol; 2005 Sep 19; 25(9):1864-70. PubMed ID: 16051878
    [Abstract] [Full Text] [Related]

  • 10. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C, Loher F, Zang C, Ismair MG, Petrides PE.
    Clin Cancer Res; 1999 May 19; 5(5):1115-24. PubMed ID: 10353746
    [Abstract] [Full Text] [Related]

  • 11. Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer.
    Kanayama H, Yokota K, Kurokawa Y, Murakami Y, Nishitani M, Kagawa S.
    Cancer; 1998 Apr 01; 82(7):1359-66. PubMed ID: 9529029
    [Abstract] [Full Text] [Related]

  • 12. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
    Lunter PC, van Kilsdonk JW, van Beek H, Cornelissen IM, Bergers M, Willems PH, van Muijen GN, Swart GW.
    Cancer Res; 2005 Oct 01; 65(19):8801-8. PubMed ID: 16204050
    [Abstract] [Full Text] [Related]

  • 13. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
    Jo M, Thomas LE, Wheeler SE, Curry TE.
    Biol Reprod; 2004 Apr 01; 70(4):1024-32. PubMed ID: 14668206
    [Abstract] [Full Text] [Related]

  • 14. Cumulative influence of matrix metalloproteinase-1 and -2 in the migration of melanoma cells within three-dimensional type I collagen lattices.
    Ntayi C, Lorimier S, Berthier-Vergnes O, Hornebeck W, Bernard P.
    Exp Cell Res; 2001 Oct 15; 270(1):110-8. PubMed ID: 11597133
    [Abstract] [Full Text] [Related]

  • 15. Type IV collagen induces matrix metalloproteinase 2 activation in HT1080 fibrosarcoma cells.
    Maquoi E, Frankenne F, Noël A, Krell HW, Grams F, Foidart JM.
    Exp Cell Res; 2000 Dec 15; 261(2):348-59. PubMed ID: 11112341
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Hwang HJ, Park HJ, Chung HJ, Min HY, Park EJ, Hong JY, Lee SK.
    J Nutr Biochem; 2006 May 15; 17(5):356-62. PubMed ID: 16214327
    [Abstract] [Full Text] [Related]

  • 17. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
    Bigg HF, Morrison CJ, Butler GS, Bogoyevitch MA, Wang Z, Soloway PD, Overall CM.
    Cancer Res; 2001 May 01; 61(9):3610-8. PubMed ID: 11325829
    [Abstract] [Full Text] [Related]

  • 18. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation.
    Muñoz-Nájar UM, Neurath KM, Vumbaca F, Claffey KP.
    Oncogene; 2006 Apr 13; 25(16):2379-92. PubMed ID: 16369494
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of tissue inhibitor of matrix metalloproteinases-1 confers the anti-invasive action of cisplatin on human cancer cells.
    Ramer R, Eichele K, Hinz B.
    Oncogene; 2007 Aug 23; 26(39):5822-7. PubMed ID: 17369856
    [Abstract] [Full Text] [Related]

  • 20. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
    Ottino P, He J, Axelrad TW, Bazan HE.
    Invest Ophthalmol Vis Sci; 2005 Feb 23; 46(2):487-96. PubMed ID: 15671273
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.